52 Week HighRanbaxy Labs has hit a 52wk high of Rs 654.70 on NSE
100% of moneycontrol users recommend buying Ranbaxy Labs.
What's your call on Ranbaxy Labs today?
Read 13 investor views
|Company Name||Last Price||%
|Dr Reddys Labs||3229.00||0.68||3353.85||2420.00||55,011.13|
|Mar' 14||Dec' 13||Sep' 13||Jun' 13|
|Scheme||No. of Shares|
|SBI Contra Fund (G)||382,384|
|SBI Magnum Balanced Fund (G)||348,589|
|ICICI Prudential Exports and Other Services Fund (G)||289,719|
|SBI Pharma Fund (G)||250,728|
Kwality Recommended on Jun 25th 2014
Recommended price 45.00 | Peak from reco 58.00 28.89%
What are Multi baggers?
Our experts panel will help you to get you those life-changing stocks, tomorrow's bluechips today.
Ranbaxy Labs is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 27,124.13 crore.The company has reported a consolidated sales of Rs 2,372.24 crore and a Net Loss of Rs -186.88 crore for the quarter ended Jun 2014.
The company management includes Tsutomu Une - Chairman, Arun Sawhney - Managing Director & CEO, Akihiro Watanabe - Director, Anthony H Wild - Director, Kazunori Hirokawa - Additional Director, Rajesh V Shah - Director, Takashi Shoda - Director, Percy K Shroff - Director.
It is listed on the BSE with a BSE Code of 500359 and the NSE with an NSE Code of RANBAXY.
Its Registered office is at A-41, Industrial Area, Phase-VIII-A,,Sahibzada Ajit Singh Nagar Mohali,Punjab - 160071.
Their Registrars are Alankit Assignment Ltd.